
Septerna, Inc. (SEPN)
Last updated: 2026-10-20 13:05:40. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.
Summary
Septerna, Inc. (SEPN) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $36.38, with a market capitalization of $1.70B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $17.55 to $51.10. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$1.70B | |
$36.38 | |
$51.10 | |
$4.17 | |
$36.38 | |
5.00 | |
387.25K | |
-- | |
$51.10 | |
$17.55 | |
-- | |
-- |
Septerna, Inc. (SEPN) Pre-Market Stock Price
Septerna, Inc. (SEPN) is trading at $36.38 in pre-market trading as of 2026-10-20 12:31:00, unchanged from the previous close of $36.38
Pre-market trading shows how investors are pricing SEPN before the regular session opens. The current pre-market price is near the previous close, indicating neutral early trading sentiment.
Septerna, Inc. (SEPN) 7-Day Stock Price Change
Over the past seven days, Septerna, Inc. (SEPN) moved from $38.37 to $36.38, representing a decline of 5.19% ($1.99).
The stock traded between $34.36 and $38.73 during the period. The latest price is near the middle of the 7-day range, indicating strong downward.
The average daily volume was 333.52 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
SEPN 52-Week Price Position
Position in Range: 56.1%
SEPN is currently trading at $36.38, placing it 56.1% of the way from its 52-week low of $17.55 to its 52-week high of $51.10. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Septerna, Inc. (SEPN)?
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, GLP-1R, GIPR, and GCGR.
Septerna, Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 130 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Septerna, Inc. (SEPN) Stock on MEXC
Eligible investors can buy real shares of Septerna, Inc. (SEPN) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Septerna, Inc. (SEPN) stock price today?
2.Is SEPN stock going up or down today?
3.What is SEPN pre-market price?
4.What is SEPN after-hours price?
5.Is SEPN stock trading now?
6.Where does SEPN sit relative to its 52-week high and low?
7.What sector is Septerna, Inc. in?
8.What is Septerna, Inc.'s market capitalization and where is it listed?
9.How is SEPN valued in terms of P/E ratio and EPS?
10.Does Septerna, Inc. pay a dividend?
Explore More US Stocks
Search Stocks
SEPN Stock Calculator
Estimate the value between SEPN shares and USD.
SEPN Shares to USD
1.00 SEPN shares = 36.38 USD
Calculations are estimates based on the latest available price and are for reference only.


